James M Downey

Title: Innovations in Cardiac Protection by James M Downey

Introduction

James M Downey is a notable inventor based in Mobile, AL, with a focus on innovations in cardiac protection. He holds four patents that contribute significantly to the field of myocardial infarction treatment. His work emphasizes the importance of combining various therapeutic agents to enhance cardioprotective effects.

Latest Patents

One of Downey's latest patents is titled "Combined administration of cysteine-aspartic protease inhibitors with P2Y12 receptor antagonists protects the heart against myocardial infarction." This patent outlines methods for treating myocardial infarction by administering a platelet anti-aggregate, a cysteine-aspartic protease inhibitor, and reperfusion therapy. The methods provide improved cardioprotective effects compared to current standard care. Another significant patent is "Method for diminishing myocardial infarction using protein phosphatase." This invention highlights the use of fostriecin and related compounds to reduce myocardial infarction size and delay cell injury onset in ischemic hearts. The method is advantageous as it can limit damage even after ischemic conditions have occurred.

Career Highlights

Throughout his career, Downey has worked with reputable organizations such as the South Alabama Medical Science Foundation and Gensia, Inc. His contributions to these institutions have been pivotal in advancing research and development in cardiac therapies.

Collaborations

Downey has collaborated with notable colleagues, including Kevin M Mullane and Richard Eric Honkanen. Their joint efforts have furthered the understanding and treatment of myocardial infarction.

Conclusion

James M Downey's innovative patents and career achievements reflect his dedication to improving cardiac health. His work continues to influence the field of myocardial infarction treatment, showcasing the importance of collaboration and innovation in medical research.